203641 Sigma-AldrichBMP-2, Human, Recombinant, E. coli
Productos recomendados
Descripción
| Replacement Information |
|---|
Tabla espec. clave
| Purity |
|---|
| ≥95% by SDS-PAGE |
| Product Information | |
|---|---|
| Form | Lyophilized |
| Formulation | Lyophilized from sterile 10 mM sodium citrate, pH 3.5. |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥95% by SDS-PAGE |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Número de referencia | GTIN |
| 203641 | 0 |
Documentation
BMP-2, Human, Recombinant, E. coli Ficha datos de seguridad (MSDS)
| Título |
|---|
BMP-2, Human, Recombinant, E. coli Certificados de análisis
| Cargo | Número de lote |
|---|---|
| 203641 |
Referencias bibliográficas
| Visión general referencias |
|---|
| Csiszar, A., et al. 2006. Am. J. Pathol. 168, 629. Kumagai, T., et al. 2006. Anticancer Res. 26, 293. Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285. Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119. Morin, R., et al. 2006. Biomacromolecules 7, 131. Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436. |



